Published in:
01-04-2018 | Head and Neck Oncology
Neoadjuvant Chemotherapy for Hypopharyngeal Squamous Cell Carcinoma and Personalized Medicine in Head and Neck Cancer
Author:
Eli Gordin, MD, FACS
Published in:
Annals of Surgical Oncology
|
Issue 4/2018
Login to get access
Excerpt
The treatment of head and neck cancer has long stood on the three pillars of surgery, chemotherapy and radiation. While the indications for and timing of administration of these modalities fluctuates, the fundamental principles of treatment have remained essentially unchanged. Therapeutic shifts have been limited to refinements in these techniques, such as minimally invasive surgery, modifications in radiation delivery, and the timing of chemotherapy administration; however, minimal improvement in survival for advanced cancers has been attained. Meanwhile, targeted therapies have shown promising results for treating cancer of the breast, colon, and lung, although head and neck cancer has enjoyed less robust success. …